223 related articles for article (PubMed ID: 20042051)
1. Successful cross-breeding of cloned pigs expressing endo-beta-galactosidase C and human decay accelerating factor.
Yazaki S; Iwamoto M; Onishi A; Miwa Y; Suzuki S; Fuchimoto D; Sembon S; Furusawa T; Hashimoto M; Oishi T; Liu D; Nagasaka T; Kuzuya T; Maruyama S; Ogawa H; Kadomatsu K; Uchida K; Nakao A; Kobayashi T
Xenotransplantation; 2009; 16(6):511-21. PubMed ID: 20042051
[TBL] [Abstract][Full Text] [Related]
2. Relation between human decay-accelerating factor (hDAF) expression in pig cells and inhibition of human serum anti-pig cytotoxicity: value of highly expressed hDAF for xenotransplantation.
Liu D; Kobayashi T; Onishi A; Furusawa T; Iwamoto M; Suzuki S; Miwa Y; Nagasaka T; Maruyama S; Kadomatsu K; Uchida K; Nakao A
Xenotransplantation; 2007 Jan; 14(1):67-73. PubMed ID: 17214706
[TBL] [Abstract][Full Text] [Related]
3. Potential value of human thrombomodulin and DAF expression for coagulation control in pig-to-human xenotransplantation.
Miwa Y; Yamamoto K; Onishi A; Iwamoto M; Yazaki S; Haneda M; Iwasaki K; Liu D; Ogawa H; Nagasaka T; Uchida K; Nakao A; Kadomatsu K; Kobayashi T
Xenotransplantation; 2010; 17(1):26-37. PubMed ID: 20149186
[TBL] [Abstract][Full Text] [Related]
4. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
[TBL] [Abstract][Full Text] [Related]
5. Production of cloned pigs expressing human thrombomodulin in endothelial cells.
Yazaki S; Iwamoto M; Onishi A; Miwa Y; Hashimoto M; Oishi T; Suzuki S; Fuchimoto D; Sembon S; Furusawa T; Liu D; Nagasaka T; Kuzuya T; Ogawa H; Yamamoto K; Iwasaki K; Haneda M; Maruyama S; Kobayashi T
Xenotransplantation; 2012; 19(2):82-91. PubMed ID: 22497510
[TBL] [Abstract][Full Text] [Related]
6. Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor.
Zhou CY; McInnes E; Copeman L; Langford G; Parsons N; Lancaster R; Richards A; Carrington C; Thompson S
Xenotransplantation; 2005 Mar; 12(2):142-8. PubMed ID: 15693845
[TBL] [Abstract][Full Text] [Related]
7. Transgenic pigs expressing human decay-accelerating factor regulated by porcine MCP gene promoter.
Murakami H; Nagashima H; Takahagi Y; Miyagawa S; Fujimura T; Toyomura K; Nakai R; Yamada M; Kurihara T; Shigehisa T; Okabe M; Seya T; Shirakura R; Kinoshita T
Mol Reprod Dev; 2002 Mar; 61(3):302-11. PubMed ID: 11835575
[TBL] [Abstract][Full Text] [Related]
8. The serum level of xenoantibodies, and hDAF or alphaGAL expression on pig cells, modulate in vitro the protection given by hDAF to primate complement-mediated damage.
Díaz TM; Mañez R; Moscoso I; López D; Santamarina I; Lopez E; Centeno A; Domenéch N
Transplant Proc; 2005; 37(1):510-1. PubMed ID: 15808692
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts.
Shimizu A; Yamada K; Yamamoto S; Lavelle JM; Barth RN; Robson SC; Sachs DH; Colvin RB
J Am Soc Nephrol; 2005 Sep; 16(9):2732-45. PubMed ID: 16049072
[TBL] [Abstract][Full Text] [Related]
10. The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts.
Zahorsky-Reeves JL; Kearns-Jonker MK; Lam TT; Jackson JR; Morris RE; Starnes VA; Cramer DV
Xenotransplantation; 2007 Mar; 14(2):135-44. PubMed ID: 17381688
[TBL] [Abstract][Full Text] [Related]
11. Production of alpha 1,3-galactosyltransferase gene knockout pigs expressing both human decay-accelerating factor and N-acetylglucosaminyltransferase III.
Takahagi Y; Fujimura T; Miyagawa S; Nagashima H; Shigehisa T; Shirakura R; Murakami H
Mol Reprod Dev; 2005 Jul; 71(3):331-8. PubMed ID: 15806557
[TBL] [Abstract][Full Text] [Related]
12. Characterization of transgenic pigs that express human decay accelerating factor and cell membrane-tethered human tissue factor pathway inhibitor.
Lee HJ; Lee BC; Kim YH; Paik NW; Rho HM
Reprod Domest Anim; 2011 Apr; 46(2):325-32. PubMed ID: 20626677
[TBL] [Abstract][Full Text] [Related]
13. In vivo gene transfer of endo-beta-galactosidase C removes alphaGal antigen on erythrocytes and endothelial cells of the organs.
Miki Y; Maruyama S; Liu D; Kobayashi T; Sato F; Shimizu H; Kato S; Sato W; Morita Y; Yuzawa Y; Muramatsu T; Matsuo S
Xenotransplantation; 2004 Sep; 11(5):444-51. PubMed ID: 15303981
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic removal of alphaGal antigen in pig kidneys by ex vivo and in vivo administration of endo-beta-galactosidase C.
Liu D; Kobayashi T; Yokoyama I; Ogawa H; Nagasaka T; Muramatsu H; Kadomatsu K; Oikawa T; Shimano Y; Morozumi K; Uchida K; Muramatsu T; Nakao A
Xenotransplantation; 2002 May; 9(3):228-36. PubMed ID: 11983021
[TBL] [Abstract][Full Text] [Related]
15. Mean xenograft survival of 14.6 days in a small group of hDAF-transgenic pig hearts transplanted orthotopically into baboons.
Brenner P; Schmoeckel M; Wimmer C; Eder V; Rucker A; Felbinger T; Uchita S; Hinz M; Brandl U; Meiser B; Reichenspurner H; Hammer C; Reichart B
Transplant Proc; 2005; 37(1):472-6. PubMed ID: 15808680
[TBL] [Abstract][Full Text] [Related]
16. Pigs transgenic for human thrombomodulin have elevated production of activated protein C.
Petersen B; Ramackers W; Tiede A; Lucas-Hahn A; Herrmann D; Barg-Kues B; Schuettler W; Friedrich L; Schwinzer R; Winkler M; Niemann H
Xenotransplantation; 2009; 16(6):486-95. PubMed ID: 20042048
[TBL] [Abstract][Full Text] [Related]
17. Xenogeneic thymokidney and thymic tissue transplantation in a pig-to-baboon model: I. Evidence for pig-specific T-cell unresponsiveness.
Barth RN; Yamamoto S; LaMattina JC; Kumagai N; Kitamura H; Vagefi PA; Awwad M; Colvin RB; Cooper DK; Sykes M; Sachs DH; Yamada K
Transplantation; 2003 May; 75(10):1615-24. PubMed ID: 12777846
[TBL] [Abstract][Full Text] [Related]
18. Hyperacute rejection of hDAF-transgenic pig organ xenografts in cynomolgus monkeys: influence of pre-existing anti-pig antibodies and prevention by the alpha GAL glycoconjugate GAS914.
Lam TT; Hausen B; Boeke-Purkis K; Paniagua R; Lau M; Hook L; Berry G; Higgins J; Duthaler RO; Katopodis AG; Robbins R; Reitz B; Borie D; Schuurman HJ; Morris RE
Xenotransplantation; 2004 Nov; 11(6):517-24. PubMed ID: 15479461
[TBL] [Abstract][Full Text] [Related]
19. Failure to deplete anti-Galalpha1-3Gal antibodies after pig-to-baboon organ xenotransplantation by immunoaffinity columns containing multiple Galalpha1-3Gal oligosaccharides.
Mañez R; Domenech N; Centeno A; Lopez-Pelaez E; Crespo F; Juffe A; Duthaler RO; Katopodis AG
Xenotransplantation; 2004 Sep; 11(5):408-15. PubMed ID: 15303977
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
